CCDC117 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.299600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.416600E-01
Normal-vs-Stage2
3.603200E-01
Normal-vs-Stage3
1.241340E-03
Normal-vs-Stage4
6.593000E-01
Stage1-vs-Stage2
4.417000E-01
Stage1-vs-Stage3
1.453960E-01
Stage1-vs-Stage4
9.559400E-01
Stage2-vs-Stage3
1.636790E-01
Stage2-vs-Stage4
5.796800E-01
Stage3-vs-Stage4
8.126100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.168800E-01
Normal-vs-AfricanAmerican
8.065600E-01
Normal-vs-Asian
1.777370E-01
Caucasian-vs-AfricanAmerican
2.877800E-01
Caucasian-vs-Asian
6.184800E-01
AfricanAmerican-vs-Asian
2.000600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.870800E-01
Normal-vs-Female
4.007000E-01
Male-vs-Female
3.550000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.775200E-01
Normal-vs-Age(41-60Yrs)
5.945600E-01
Normal-vs-Age(61-80Yrs)
2.638800E-01
Normal-vs-Age(81-100Yrs)
1.464840E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.122200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.828400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.682800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.403600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.131500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.466400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.514400E-02
Normal-vs-Daily Drinker
9.495500E-03
Normal-vs-Weekly Drinker
3.817800E-01
Normal-vs-Occasional Drinker
3.854400E-01
Normal-vs-Social Drinker
5.556800E-01
Non Drinker-vs-Daily Drinker
2.438400E-01
Non Drinker-vs-Weekly Drinker
1.542790E-01
Non Drinker-vs-Occasional Drinker
1.929610E-01
Non Drinker-vs-Social Drinker
4.358400E-02
Daily Drinker-vs-Weekly Drinker
5.077600E-02
Daily Drinker-vs-Occasional Drinker
4.182400E-02
Daily Drinker-vs-Social Drinker
7.016600E-03
Weekly Drinker-vs-Occasional Drinker
6.007400E-01
Weekly Drinker-vs-Social Drinker
9.627800E-01
Occasional Drinker-vs-Social Drinker
5.770800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.129800E-01
Normal-vs-Grade 2
8.450800E-01
Normal-vs-Grade 3
8.082200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.305400E-01
Grade 1-vs-Grade 3
9.204000E-01
Grade 1-vs-Grade 4
8.129800E-01
Grade 2-vs-Grade 3
2.787000E-01
Grade 2-vs-Grade 4
8.450800E-01
Grade 3-vs-Grade 4
8.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.213000E-01
Normal-vs-NonDiabetic
2.255400E-01
Diabetic-vs-NonDiabetic
7.662400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.015200E-01
Normal-vs-NoPancreatitis
2.632800E-01
Pancreatitis-vs-NoPancreatitis
7.495000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.098800E-01
Normal-vs-N1
3.686400E-01
N0-vs-N1
4.434800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.957200E-01
Normal-vs-TP53-NonMutant
7.419800E-01
TP53-Mutant-vs-TP53-NonMutant
2.182200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
